Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G, De Souza C, Aversa S, Patti C, Tedeschi L, Candela M, Olivieri A, Chisesi T, Rubagotti A, Centurioni R, Nardi V, Congiu M, Gennaro M, Truini M; Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Santini G, et al. Among authors: congiu m. Braz J Med Biol Res. 2004 May;37(5):719-28. doi: 10.1590/s0100-879x2004000500014. Epub 2004 Apr 22. Braz J Med Biol Res. 2004. PMID: 15107935 Free article. Clinical Trial.
Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Non-Hodgkin's Lymphoma Cooperative Study Group.
Chisesi T, Congiu M, Contu A, Coser P, Moretti L, Porcellini A, Rancan L 6th, Salvagno L, Santini G, Vinante O. Chisesi T, et al. Among authors: congiu m. Eur J Cancer. 1991;27 Suppl 4:S31-3. doi: 10.1016/0277-5379(91)90566-v. Eur J Cancer. 1991. PMID: 1799472 Clinical Trial.
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.
Clavio M, Miglino M, Spriano M, Pietrasanta D, Vallebella E, Celesti L, Canepa L, Pierri I, Cavaliere M, Ballerini F, Beltrami G, Rossi E, Vimercati R, Bruni R, Congiu M, Nati S, Damasio E, Santini G, Gobbi M. Clavio M, et al. Among authors: congiu m. Eur J Haematol. 1998 Sep;61(3):197-203. doi: 10.1111/j.1600-0609.1998.tb01084.x. Eur J Haematol. 1998. PMID: 9753416
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Carella AM, Prencipe E, Pungolino E, Lerma E, Frassoni F, Rossi E, Giordano D, Occhini D, Gatti AM, Bruni R, Spriano M, Nati S, Pierluigi D, Congiu M, Vimercati R, Ravetti JL, Federico M. Carella AM, et al. Among authors: congiu m. Leuk Lymphoma. 1996 Mar;21(1-2):63-70. doi: 10.3109/10428199609067581. Leuk Lymphoma. 1996. PMID: 8907271 Clinical Trial.
Aplastic anemia: pathogenesis and treatment.
Bacigalupo A, Piaggio G, Van Lint MT, Figari O, Marmont A, Congiu M. Bacigalupo A, et al. Among authors: congiu m. Onkologie. 1987 Jun;10(3):172-3. doi: 10.1159/000216399. Onkologie. 1987. PMID: 3306537
141 results